2651089 is referenced by 36 patents.

The invention relates to polymorphic crystal modifications of 1-((4-methyl-quinazolin-2-yl)methyl)-3,7-(2-butyn-1-yl)-8-(3-(R)- aminopiperidin-1-yl)xanthine, their production and their use for the preparation of a medicament.

La présente invention concerne des modifications cristallines polymorphes de 1-((4-méthyl-quinazolin-2-yl)méthyl)-3-7-(2-butin-1-yl)-8-(3-(R)-amino-pipéridin-1-yl)-xanthine, leur préparation et leur utilisation pour fabriquer un médicament.

Title
UNE FORME POLYMERIQUE DE 1-((4-METHYL-QUINAZOLIN-2-YL)METHYL)-3-7-(2-BUTYN-1YL)-8-(3-(R)-AMINOPIPERIDIN-1-YL)XANTHINE
A POLYMERIC FORM OF 1-((4-METHYL-QUINAZOLIN-2-YL)METHYL)-3-7-(2-BUTYN-1-YL)-8-(3-(R)-AMINOPIPERIDIN-1-YL)XANTHINE
Publication Number
2651089
Publication Date
February 20, 2018
Inventor
RENZ MARTIN
NICOLA THOMAS
KOHLBAUER PETER
KEMMER DIRK
SIEGER PETER
Agent
FETHERSTONHAUGH & CO
Assignee
BOEHRINGER INGELHEIM INTERNATIONAL
Assignee
BOEHRINGER INGELHEIM INTERNATIONAL
IPC
A61P 3/10
A61K 31/522
C07D 473/04
View Original Source